|
Volumn 13, Issue 7, 2002, Pages 759-765
|
15-Deoxy-δ12,14-prostaglandin J2 induces apoptosis of a thyroid papillary cancer cell line (CG3 cells) through increasing intracellular iron and oxidative stress
a a a a a |
Author keywords
15 Deoxy 12,14 prostaglandin J2; Apoptosis; Free iron; Oxidative stress; Thyroid papillary carcinoma
|
Indexed keywords
15 DEOXY DELTA12,14 PROSTAGLANDIN J2;
ACETYLCYSTEINE;
ALLOPURINOL;
CATALASE;
CYCLOSPORIN A;
DEFEROXAMINE;
DIPHENYLIODONIUM SALT;
IRON;
N(G) METHYLARGININE ACETATE;
NITRIC OXIDE SYNTHASE INHIBITOR;
OLIGOMYCIN;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
REACTIVE OXYGEN METABOLITE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
ROTENONE;
UNCLASSIFIED DRUG;
XANTHINE OXIDASE INHIBITOR;
15 DEOXY DELTA(12,14) PROSTAGLANDIN J2;
15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2;
BIOLOGICAL RESPONSE MODIFIER;
CASPASE;
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;
IRON CHELATING AGENT;
PROSTAGLANDIN D2;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
CONTROLLED STUDY;
CYTOTOXICITY;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IRON CHELATION;
IRON STORAGE;
MITOCHONDRIAL RESPIRATION;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
THYROID PAPILLARY CARCINOMA;
CELL COUNT;
CELL CULTURE;
CELL SURVIVAL;
DRUG EFFECT;
ENZYME ACTIVATION;
LIPID PEROXIDATION;
METABOLISM;
PAPILLARY CARCINOMA;
PATHOLOGY;
STIMULATION;
THYROID TUMOR;
APOPTOSIS;
BIOLOGICAL RESPONSE MODIFIERS;
CARCINOMA, PAPILLARY;
CASPASES;
CELL COUNT;
CELL SURVIVAL;
ENZYME ACTIVATION;
HUMANS;
INDICATORS AND REAGENTS;
IRON;
IRON CHELATING AGENTS;
LIPID PEROXIDATION;
OXIDATIVE STRESS;
PROSTAGLANDIN D2;
REACTIVE OXYGEN SPECIES;
STIMULATION, CHEMICAL;
THYROID NEOPLASMS;
TUMOR CELLS, CULTURED;
|
EID: 0036667949
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: 10.1097/00001813-200208000-00011 Document Type: Article |
Times cited : (21)
|
References (26)
|